Inhalation Sciences (ISAB)

Inhalation Sciences Sweden, ISAB, is a research company. Today, the main focus is on the production and development of laboratory instruments. The instruments are used to measure particles in inhalation air, and to measure how the composition of the air affects the lungs. The company sells products under various trademarks, mainly on the European market. Inhalation Sciences Sweden was founded in 2004 and is based in Huddinge.

Quotes for Inhalation Sciences Sweden AB

Right Now

+/-: -0.044
%: −5,06%
Latest: 0.826
High: 0.888
Low: 0.8
Volume: 35 039
Turnover (SEK): 28 474
Market Value (MSEK): 12,5
Time (Latest trade)

Board

CEO

Manoush Masarrat

Chairperson of the Board

Daniel Spasic

Board

Jan Hellqvist
Per Gerde
Sonja Gerde
Ulf Ericsson

Articles of association

News

2025-03-03 10:35:25 Inhalation Sciences well-positioned as FDA emphasizes dissolution testing for inhalation studies
2025-02-28 08:30:00 Inhalation Sciences AB (publ) publicerar bokslutskommuniké 2024
2025-02-28 08:30:00 Inhalation Sciences AB (publ) releases Q4 / Year-End Report 2024
2025-01-13 08:30:00 Inhalation Sciences’ launch of the XposeALI[®] in vitro module with microperfusion
2025-01-10 08:30:00 Inhalation Sciences receives IRS order worth SEK 212,000 from global leader in generics and biosimilars

News agencies

2025-03-03 11:55:42 Finwire: Inhalation Sciences välkomnar FDA:s nya riktlinjer
2025-02-28 08:38:11 Finwire: Inhalation Sciences minskar resultat och orderingång - ser över olika alternativ för finansiering
2025-01-13 08:49:14 Finwire: Inhalation Sciences ska lansera XposeALI med mikroperfusion
2025-01-10 08:36:56 Finwire: Inhalation Sciences får IRS-order värd 212 000 kronor
2025-01-09 08:44:12 Finwire: Inhalation Sciences lämnar in rapport och sammanfattande data till FDA för DissolvIt-projekt

Analysis

2024-03-12 Redeye: Inhalation Sciences: Clinical study results - Redeye
2024-02-29 Redeye: Inhalation Sciences Q4: Rising revenues and close to break even - Redeye
2024-01-22 Redeye: Inhalation Sciences: Partnership with Actarmo Medical - Redeye
2023-11-23 Redeye: Inhalation Sciences Q3: Continuing its journey towards profitability - Redeye
2023-11-13 Redeye: Inhalation Sciences: A PreciseInhale order - Redeye

Videos

Largest Owners

Name	Capital %	Votes %	Date
Avanza Pension	10,71	10,71	2024-12-23
Leo Graf	7,83	7,83	2024-12-23
Per Gerde	5,63	5,63	2024-12-23
Nordnet Pensionsförsäkring	4,34	4,34	2024-12-23
Tobias Granberg	3,56	3,56	2024-12-23
Tuvedalen Ltd	3,07	3,07	2024-12-23
Alexander Bäck	2,89	2,89	2024-12-23
Försäkringsaktiebolaget Skandia	2,41	2,41	2024-12-23
Mattias Karlsson	2,21	2,21	2024-12-23
Georg Petersen	2,19	2,19	2024-12-23

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Quotes for Inhalation Sciences Sweden AB

Right Now

Board

News

News agencies

Analysis

Videos

Inhalation Sciences 240229

Inhalation Sciences | VD Manoush Masarrat - "Samarbetet med FDA kommer ge större volymer"

Hemma hos Inhalation Sciences

Inhalation sitdown

Largest Owners

Insider trading

Key Numbers

Upcoming reports

Annual reports, prospectus etc.